Bespoke Extracts (BSPK) Other financing activities (2022 - 2023)

Bespoke Extracts' (BSPK) quarterly Other financing activities came in at $97303.0 in Q3 2023, down 42.99% year-on-year from $170682.0 in Q3 2022, and up 5.37% quarter-over-quarter from $92344.0 in Q2 2023.

Bespoke Extracts (BSPK) Other financing activities (2022 - 2023) Analysis & Trends

Bespoke Extracts has disclosed Other financing activities across 2 years of filings, most recently posting $97303.0 for Q3 2023.

  • Other financing activities for Q3 2023 came in at $97303.0, down 42.99% year-over-year; the trailing twelve-month figure through Sep 2023 was -$1.4 million (changed N/A YoY), and the FY2022 annual result was $4793.0, changed N/A from the prior year.
  • Other financing activities came in at $97303.0 for Q3 2023 at Bespoke Extracts, up from $92344.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $727606.0 in Q1 2022 to a low of -$1.6 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Bespoke Extracts - - 234,175.00

Historic Data

Download Data
DateValue
Sep 30, 2023 97,303.00
Sep 30, 2023 97,303.00
Jun 30, 2023 92,344.00
Jun 30, 2023 92,344.00
Mar 31, 2023 90,000.00
Mar 31, 2023 90,000.00
Dec 31, 2022 -1.64 Mn
Dec 31, 2022 -1.64 Mn
Sep 30, 2022 170,682.00
Sep 30, 2022 170,682.00
Jun 30, 2022 708,253.00
Jun 30, 2022 708,253.00
Mar 31, 2022 727,606.00
Mar 31, 2022 727,606.00